Virtual Advisory Committees Are Here, And They Will Take Some Getting Used To

The first virtual US FDA advisory committee review of a drug application was nearly a disaster, but the second proved that the concept can work. Nevertheless, things are going to be very different for sponsors, even when the technology is perfected.